Navigation Links
Human Pheromone Sciences Announces First Quarter Results
Date:5/14/2009

Current Period Results Impacted by Downturn in Worldwide Beauty Markets

SAN JOSE, Calif., May 14 /PRNewswire-FirstCall/ -- Human Pheromone Sciences, Inc. (OTC Bulletin Board: EROX) ("HPS" or the "Company") today announced results for the first quarter ended March 31, 2009. Net revenues of $165,000 represented a 38% decrease from the revenues of $266,000 in the prior year period, and resulted in a net loss of $181,000 ($0.04 per share) as compared with net loss of $63,000 ($0.02 per share) for the same period of 2008. At March 31, 2009, the Company reflected cash balances of $664,000 compared with $907,000 in cash at December 31, 2008, a $243,000 reduction in the quarter. There was no bank indebtedness at either period.

According to a Company spokesperson, "the revenue and cash declines were in line with the Company's internal forecasts, reflecting the extremely difficult overall adverse economic climate and the significant downturn in the worldwide Fragrance and Beauty Markets. We had anticipated the reduction of revenues on sales to our once largest fragrance and beauty-based company, and, as such, embarked upon a program to expand other potential markets for the use of our patented technology in other consumer product arenas. Some of the shortfall in the basic beauty area was offset by supply and royalty revenues received under our licensing agreement with Schwarzkopf & Henkel in the worldwide hair care and personal product markets. Pheromone purchases by our two primary licensees, increased by 79%, in anticipation of a new product launch in May 2009 by one of these companies. While the selling price of the pheromones is quite low compared to that of prior licensees, our newer agreements provide for royalties on licensee sales of products containing our patented technology. As such, we would anticipate an increase in royalty income in subsequent periods this year."

"Generating additional revenue
'/>"/>

SOURCE Human Pheromone Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Embryonic Stem Cells Repair Human Heart
2. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
3. Human Papilloma Virus vaccines may decrease chances of oral cancer
4. Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds
5. MassMutual Promotes Debra Palermino to Senior Vice President of Human Resources
6. Toddler Study Proves Humans Outsmart Apes
7. Human C-reactive protein regulates myeloma tumor cell growth and survival
8. Altered expression of ultraconserved noncoding RNAs linked to human leukemias and carcinomas
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. New class of RNA molecules may be important in human cancer
11. The Humana Foundation and Libraries for the Future Launch Health Literacy Pilot in Atlanta
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... Dec. 17 Reportlinker.com announces that ... in its catalogue: ,, India Healthcare ... 2015 ,, http://www.reportlinker.com/p0169911/India-Healthcare-IT-Investment-Opportunities-Analysis-and-Forecasts-to-2015.html ,, ... Forecasts to 2015 ,, Summary ... for in-depth information and data relating to ...
(Date:12/17/2009)... YORK, Dec. 17 Reportlinker.com ... report is available in its catalogue: ... strategic assessment of the competitive environment ... the highest priority management responsibilities, the ... and profitability. Timely and factual competitive ...
(Date:12/17/2009)... 17 Today, CDC,s Morbidity and Mortality ... the number of state-level epidemiologists has decreased steadily ... 10% since 2006. There was also a substantial ... period, including epidemiology capacity for bioterrorism and emergency ... such as occupational health, substance abuse, and oral ...
(Date:12/17/2009)... Dec. 17 /PRNewswire-Asia/ -- China,s leading high-tech,healthcare group, ... Stock Code: 801) is pleased to announce today ... (FunTalk), formerly known as,Pypo China Holdings Limited, made ... ) after a successful secondary offering. The shares ... (Eastern Time). , As ...
(Date:12/17/2009)... HONG KONG, Dec. 17 /PRNewswire-Asia/ -- China,s leading ... or "the,Group"; Stock Code: 801) is pleased to ... During the period under review, the Group,s two,associate ... Stock Exchange and NASDAQ;,its key businesses have been ... new hospital management operations. , ...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds India Healthcare IT Investment Opportunities, Analysis and Forecasts to 2015 2Health News:Reportlinker Adds India Healthcare IT Investment Opportunities, Analysis and Forecasts to 2015 3Health News:Reportlinker Adds India Healthcare IT Investment Opportunities, Analysis and Forecasts to 2015 4Health News:Reportlinker Adds India Healthcare IT Investment Opportunities, Analysis and Forecasts to 2015 5Health News:Reportlinker Adds India Healthcare IT Investment Opportunities, Analysis and Forecasts to 2015 6Health News:Reportlinker Adds India Healthcare IT Investment Opportunities, Analysis and Forecasts to 2015 7Health News:Reportlinker Adds India Healthcare IT Investment Opportunities, Analysis and Forecasts to 2015 8Health News:Reportlinker Adds Top Ten World's Leading Life Science Intermediates Companies 2Health News:CSTE National Assessment Finds Critical Public Health Disease Surveillance Capacity Lacking 2Health News:Golden Meditech's Associate Company Debuted on NASDAQ 2Health News:Golden Meditech Announces Interim Results of FY2009/10 2Health News:Golden Meditech Announces Interim Results of FY2009/10 3
... June 23 ,Debiotech and STMicroelectronics (NYSE: ... a unique miniaturized insulin-delivery pump. The,tiny device ... patch to provide continuous,insulin infusion, enabling substantial ... quality of life of diabetes patients. The,breakthrough ...
... to support the Coordinating Office for Terrorism Preparedness and ... ... Martin (NYSE: LMT ) was,selected by the Centers for Disease ... Coordinating Office for,Terrorism Preparedness and Emergency Response (COTPER) in Atlanta. This,task ...
... chronic inflammatory rheumatic disease, associated with stiffening of the ... been diagnosed in Germany, but milder forms of the ... by Dr. Roland R. Wick, with Dr. Elke A. ... Prof. Dr. Wolfgang Gssner have conducted a long-term follow-up ...
... of early-stage tumors, researchers say, , , MONDAY, June 23 (HealthDay ... ovarian cancer detection by 20 percent through use of a ... a woman,s report of new-onset symptoms. , Using either ... cancers in a high-risk group of women, while the two ...
... to, Convenience Stores, Gas Stations, Bodegas, Independent Pharmacies ... Health Food Stores in the ... MedeFile,International, Inc. (OTC Bulletin Board: MDFI), a company specializing in,portable ... South Florida-based API Marketing, Sales & Advertising,Company the exclusive right ...
... 23 Medco Health,Solutions, Inc. (NYSE: MHS ... Health Care, Inc. (NYSE: CVH ), a ... Medco, the leading independent pharmacy benefits manager, ... all of Coventry,s Medicare,programs, covering approximately one million ...
Other Medicine News:Health News:STMicroelectronics and Debiotech Announce First Prototypes of Disposable Insulin Nanopump 2Health News:STMicroelectronics and Debiotech Announce First Prototypes of Disposable Insulin Nanopump 3Health News:Lockheed Martin Wins $24 Million IT Contract With CDC 2Health News:Increased cancer risk following the use of radioactive Radium-224 in the therapy 2Health News:Symptoms Plus Blood Test Boost Ovarian Cancer Detection 2Health News:Symptoms Plus Blood Test Boost Ovarian Cancer Detection 3Health News:MedeFile To Be Marketed in Over 100,000 Retail Outlets 2Health News:MedeFile To Be Marketed in Over 100,000 Retail Outlets 3Health News:MedeFile To Be Marketed in Over 100,000 Retail Outlets 4Health News:Coventry Health Care Awards Medicare Pharmacy Services Contract to Medco 2Health News:Coventry Health Care Awards Medicare Pharmacy Services Contract to Medco 3
(Date:12/17/2009)... Decision Resources, one of the world,s leading research ... finds that the cost of Roche/Chugai,s Avastin, followed ... are cited most frequently by surveyed oncologists as ... non-small-cell lung cancer treatment in Germany, France, Italy, ... Special European Physician & Payer Forum report entitled ...
(Date:12/17/2009)... ORLANDO, Fla., Dec. 17 MedX Limited, ... -branded medical exercise equipment and a subsidiary of ... the sale of 227 MedX exercise ... list of countries, including Australia, Germany, India, Scotland, ... sold MedX equipment will be used ...
(Date:12/17/2009)... Inc., (OTC Bulletin Board: SCIE) disclosed today that its ... letter to shareholders: ,, As the end of the ... the recent closing of a $4.3 million round of ... ramping our business performance as we head into 2010. ... force. We are increasing our sales and marketing activities ...
Breaking Medicine Technology:Surveyed European Oncologists Cite Cost Most Frequently as the Factor Preventing Their Use of Avastin for Non-Small-Cell Lung Cancer 2Surveyed European Oncologists Cite Cost Most Frequently as the Factor Preventing Their Use of Avastin for Non-Small-Cell Lung Cancer 3WellTek Subsidiary MedX Limited Increases Presence in Global Market 2WellTek Subsidiary MedX Limited Increases Presence in Global Market 3WellTek Subsidiary MedX Limited Increases Presence in Global Market 4SpectraScience Releases Shareholder Newsletter 2SpectraScience Releases Shareholder Newsletter 3SpectraScience Releases Shareholder Newsletter 4SpectraScience Releases Shareholder Newsletter 5Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 1Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 2Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 3Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 4Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 5Abbott Cuts Use of Oil and Coal by 35 Percent 5108 1Abbott Cuts Use of Oil and Coal by 35 Percent 5108 2Abbott Cuts Use of Oil and Coal by 35 Percent 5108 3Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth 5106 1Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth 5106 2
... American Association for Cancer Research,annual meeting -, ... Inc. today presented preclinical data demonstrating potent,anti- ... the,efficacy and safety in animal models of ... are both attractive targets,for an antibody-drug conjugate ...
... OncoGenex Technologies,Inc. announced today data from a Phase II ... with metastatic breast,cancer (MBC). Data was presented by the ... the American Association for,Cancer Research 2007 Annual Meeting in ... concluded:, - ...
Other Medicine Technology:Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 2Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 3Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 4OncoGenex Technologies Announces Phase II Data of OGX-011 in,Metastatic Breast Cancer at American Association for Cancer,Research 2007 Annual Meeting 2OncoGenex Technologies Announces Phase II Data of OGX-011 in,Metastatic Breast Cancer at American Association for Cancer,Research 2007 Annual Meeting 3OncoGenex Technologies Announces Phase II Data of OGX-011 in,Metastatic Breast Cancer at American Association for Cancer,Research 2007 Annual Meeting 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: